Last updated: October 3, 2022
Sponsor: Princess Margaret Hospital, Hong Kong
Overall Status: Active - Recruiting
Phase
3
Condition
Kidney Stones
Treatment
N/AClinical Study ID
NCT05570084
KW/FR-19-075-(139-02)
Ages > 18 All Genders
Study Summary
Eligibility Criteria
Inclusion
Inclusion criteria:
- Presented with radio-opaque ureteric stone of size 5mm to 10mm on KUB
- Patients who can understand the study protocol and comply with the followup schedule
Exclusion
Exclusion criteria:
- Radiolucent stone
- Paper thin cortex
- Non-functioning kidney
- Renal insufficiency (serum creatinine greater than 1.8 mg/dl or 160umol/dL)
- Concurrent urosepsis
- Current [alpha]-blocker usage, Ca channel blocker, steroid
- Pregnancy
- Age < 18
- History of ureteral stricture
- History of ureteric stone treatment within 2 years
- Allergic reaction to the study medication
- Unable to Consent
- Patient on JJ stent or PCN drainage
Study Design
Total Participants: 80
Study Start date:
May 31, 2022
Estimated Completion Date:
December 31, 2023
Connect with a study center
Hong Kong
Hong Kong,
Hong KongActive - Recruiting
Not the study for you?
Let us help you find the best match. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.